Clinical trial
Gene Therapy for the Treatment of Brain Tumors
NCT00001328 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00001328 |
|---|---|
| Title | Gene Therapy for the Treatment of Brain Tumors |
| Official title | Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction With the Thymidine Kinase Gene and Intravenous Ganciclovir |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain Neoplasm, Neoplasm Metastasis |
| Intervention type | Device, Drug |
| Interventions | Cytovene (Ganciclovir Sodium), G1TKSVNa.53 Producer Cell Line |
| Enrollment | 15 |
| Start date | Aug 21, 1992 |
| Primary completion | Apr 30, 2010 |
| Completion | Apr 30, 2010 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: